Lung Cancer Clinical Trial
Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research
Summary
The study objective is to collect biospecimen samples (e.g., whole blood) from participants diagnosed with active lung cancer to investigate the immune response to develop treatments and therapies.
Eligibility Criteria
Inclusion Criteria:
Participants willing and able to provide written informed consent
Participants are willing and able to provide appropriate photo identification
Participant's age 18 - 100 years old
Participants diagnosed with active non-small cell lung cancer (Adenocarcinoma or Squamous Cell only. All stages are acceptable.)
Participants must have associated tissue biomarker data (EFGR and MET mutations) in their medical records
Exclusion Criteria:
Participants who are pregnant or nursing
Participants with a known history of HIV, hepatitis, or other infectious diseases
Participants who have taken an investigational product in the last 30 days
Participants who have experienced excess blood loss, including blood donation defined as 250 mL in the last month or 500 mL in the previous two months
Participants currently enrolled in a clinical trial
Participants currently in remission
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Waltham Massachusetts, 02451, United States More Info
Principal Investigator
How clear is this clinincal trial information?